Few countries can match India on scale and complexity of a nationwide rollout of any item under the sun. Be it the general elections or the covid-19 inoculation plan of over 300m citizens by the end of the summer. India faces a daunting task but appears to be up for it. Covaxin, the home-grown vaccine has kicked up some controversy. Data of stage 3 clinical trials have not been yet made available. How are other countries faring? And in other news the legendary Mahinder Watsa, a trained obstetrician-gynaecologist-turned-sexpert passed away recently. He was known for his witty and dry remarks on all things sex. And which is Japan's oldest company still alive and kicking?

Hosted on Acast. See acast.com/privacy for more information.